Is Hillevax Stock a Good Investment?

Hillevax Investment Advice

  HLVX
To provide specific investment advice or recommendations on Hillevax stock, we recommend investors consider the following general factors when evaluating Hillevax. This will help you to make an informed decision on whether to include Hillevax in one of your diversified portfolios:
  • Examine Hillevax's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Hillevax's leadership team and their track record. Good management can help Hillevax navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Hillevax's business and its evolving consumer preferences.
  • Compare Hillevax's performance and market position to its competitors. Analyze how Hillevax is positioned in terms of product offerings, innovation, and market share.
  • Check if Hillevax pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Hillevax's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Hillevax stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Hillevax is a good investment.
 
Sell
 
Buy
Hold
We provide advice to complement the regular expert consensus on Hillevax. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Hillevax is not overpriced, please check out all Hillevax fundamentals, including its cash per share, as well as the relationship between the short ratio and total asset . Please also validate Hillevax number of shares shorted to confirm your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Market Performance

WeakDetails

Volatility

Not too volatileDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

HighDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Hillevax Stock

Researching Hillevax's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 17.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hillevax recorded a loss per share of 3.09. The entity had not issued any dividends in recent years.
To determine if Hillevax is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Hillevax's research are outlined below:
Hillevax may become a speculative penny stock
Hillevax has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (123.57 M) with profit before overhead, payroll, taxes, and interest of 0.
Hillevax currently holds about 292.06 M in cash with (86.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.81, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Hillevax has a frail financial position based on the latest SEC disclosures
Over 75.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: HilleVax, Inc. Short Interest Update - MarketBeat
Hillevax uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Hillevax. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Hillevax's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
15th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Hillevax's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Hillevax's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-30-0.4245-0.52-0.095522 
2024-08-09
2024-06-30-0.7814-0.65950.121915 
2024-05-09
2024-03-31-0.84-0.97-0.1315 
2023-08-14
2023-06-30-0.9-0.740.1617 
2023-05-12
2023-03-31-0.94-0.710.2324 
2022-11-10
2022-09-30-0.91-0.450.4650 
2023-03-17
2022-12-31-1.46-0.560.961 
2022-08-10
2022-06-30-0.78-2.03-1.25160 

Know Hillevax's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Hillevax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hillevax backward and forwards among themselves. Hillevax's institutional investor refers to the entity that pools money to purchase Hillevax's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
627.7 K
State Street Corp2024-06-30
595.4 K
Qiming U.s. Ventures Management, Llc2024-09-30
558.9 K
Millennium Management Llc2024-06-30
490 K
Trium Capital Llp2024-09-30
453.3 K
Deutsche Bank Ag2024-06-30
311.6 K
Northern Trust Corp2024-09-30
242.7 K
Catalys Pacific Llc2024-09-30
236.4 K
Citadel Advisors Llc2024-09-30
175.5 K
Tang Capital Management Llc2024-09-30
4.9 M
Blackrock Inc2024-06-30
2.1 M
Note, although Hillevax's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hillevax's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 96.62 M.

Market Cap

481.7 Million

Hillevax's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.36)(0.38)
Return On Capital Employed(0.42)(0.40)
Return On Assets(0.36)(0.38)
Return On Equity(0.47)(0.44)
Determining Hillevax's profitability involves analyzing its financial statements and using various financial metrics to determine if Hillevax is a good buy. For example, gross profit margin measures Hillevax's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Hillevax's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Hillevax's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hillevax. Check Hillevax's Beneish M Score to see the likelihood of Hillevax's management manipulating its earnings.

Evaluate Hillevax's management efficiency

Hillevax has return on total asset (ROA) of (0.289) % which means that it has lost $0.289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6224) %, meaning that it created substantial loss on money invested by shareholders. Hillevax's management efficiency ratios could be used to measure how well Hillevax manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.38 in 2024. Return On Capital Employed is likely to rise to -0.4 in 2024. At this time, Hillevax's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 2 M in 2024, whereas Total Assets are likely to drop slightly above 173.7 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 6.54  6.87 
Tangible Book Value Per Share 6.54  6.87 
Enterprise Value Over EBITDA(3.67)(3.85)
Price Book Value Ratio 2.45  2.58 
Enterprise Value Multiple(3.67)(3.85)
Price Fair Value 2.45  2.58 
Enterprise Value486.1 M580.6 M
The leadership approach at Hillevax's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta
0.773

Basic technical analysis of Hillevax Stock

As of the 26th of November, Hillevax retains the Market Risk Adjusted Performance of 0.0218, downside deviation of 2.16, and Risk Adjusted Performance of 0.0143. Hillevax technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Hillevax's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hillevax insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hillevax's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hillevax insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Frazier Life Sciences X, L.p. over three weeks ago
Disposition of 2736234 shares by Frazier Life Sciences X, L.p. of Hillevax at 13.6 subject to Rule 16b-3
 
Gerberding Julie L. over three weeks ago
Disposition of tradable shares by Gerberding Julie L. of Hillevax subject to Rule 16b-3
 
Borkowski Astrid over a month ago
Disposition of 10000 shares by Borkowski Astrid of Hillevax at 14.2 subject to Rule 16b-3
 
Aditya Kohli over a month ago
Disposition of 8866 shares by Aditya Kohli of Hillevax at 14.9315 subject to Rule 16b-3
 
Borkowski Astrid over two months ago
Disposition of 10000 shares by Borkowski Astrid of Hillevax at 14.5 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.205 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 15.4482 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 723 shares by Aditya Kohli of Hillevax at 14.1542 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.0135 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 14.7075 subject to Rule 16b-3
 
Sean McLoughlin over six months ago
Acquisition by Sean McLoughlin of 1250 shares of Hillevax at 16.98 subject to Rule 16b-3
 
Aditya Kohli over six months ago
Disposition of 6000 shares by Aditya Kohli of Hillevax at 17.4153 subject to Rule 16b-3

Hillevax's Outstanding Corporate Bonds

Hillevax issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hillevax uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hillevax bonds can be classified according to their maturity, which is the date when Hillevax has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Hillevax's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Hillevax's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Hillevax's intraday indicators

Hillevax intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hillevax stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Hillevax time-series forecasting models is one of many Hillevax's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hillevax's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Hillevax Stock media impact

Far too much social signal, news, headlines, and media speculation about Hillevax that are available to investors today. That information is available publicly through Hillevax media outlets and privately through word of mouth or via Hillevax internal channels. However, regardless of the origin, that massive amount of Hillevax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hillevax news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hillevax relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hillevax's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hillevax alpha.

Hillevax Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hillevax can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Hillevax Corporate Management

Anju ChatterjiVP OperationsProfile
Kaia AgarwalVP AffairsProfile
Astrid MDChief OfficerProfile
Sean McLoughlinChief OfficerProfile
Paul JDSecretary CounselProfile
Ozzie BergerSenior AffairsProfile

Additional Tools for Hillevax Stock Analysis

When running Hillevax's price analysis, check to measure Hillevax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hillevax is operating at the current time. Most of Hillevax's value examination focuses on studying past and present price action to predict the probability of Hillevax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hillevax's price. Additionally, you may evaluate how the addition of Hillevax to your portfolios can decrease your overall portfolio volatility.